Instrument Inactif

Progenics Pharmaceuticals, Inc.

Actions

Publié le 05/10/2018 à 14:30

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, ladies and gentlemen, and welcome to the Progenics Conference Call to discuss results of Phase II/III trial of PyL. [Operator Instructions]

Débloquer l'article : ABONNEZ-VOUS !

Vous êtes déja client ? Se connecter

01/03/24	Perspective Therapeutics, Inc. (NYSEAM:CATX) a conclu l'acquisition d'une installation de fabrication de produits radiopharmaceutiques à Somerset, dans le New Jersey, auprès de Progenics Pharmaceuticals, Inc.	CI
07/05/20	Transcript : Progenics Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 07, 2020
23/12/19	Transcript : Progenics Pharmaceuticals, Inc. - Special Call
07/11/19	Progenics Pharmaceuticals, Inc. fournit des prévisions de revenus pour l'année 2019	CI
02/10/19	Transcript : Lantheus Holdings, Inc., Progenics Pharmaceuticals, Inc. - M&A Call
09/08/19	Transcript : Progenics Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 09, 2019
09/05/19	Transcript : Progenics Pharmaceuticals, Inc., Q1 2019 Earnings Call, May 09, 2019
14/03/19	Transcript : Progenics Pharmaceuticals, Inc., Q4 2018 Earnings Call, Mar 14, 2019
13/11/18	Transcript : Progenics Pharmaceuticals, Inc. Presents at 27th Annual Credit Suisse Healthcare Conference, Nov-13-2018 09:10 AM
08/11/18	Transcript : Progenics Pharmaceuticals, Inc., Q3 2018 Earnings Call, Nov 08, 2018
05/10/18	Transcript : Progenics Pharmaceuticals, Inc. - Special Call
31/07/18	Transcript : Progenics Pharmaceuticals, Inc. - Special Call
09/05/18	Transcript : Progenics Pharmaceuticals, Inc., Q1 2018 Earnings Call, May 09, 2018
08/03/18	Transcript : Progenics Pharmaceuticals, Inc., Q4 2017 Earnings Call, Mar 08, 2018
02/11/17	Transcript : Progenics Pharmaceuticals, Inc., Q3 2017 Earnings Call, Nov 02, 2017

Durée

Période

Secteur